» Articles » PMID: 26973885

Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing

Overview
Journal Cell Syst
Publisher Cell Press
Date 2016 Mar 15
PMID 26973885
Citations 169
Authors
Affiliations
Soon will be listed here.
Abstract

Bacteria are central to human health and disease, but existing tools to edit microbial consortia are limited. For example, broad-spectrum antibiotics are unable to accurately manipulate bacterial communities. Bacteriophages can provide highly specific targeting of bacteria, but assembling well-defined phage cocktails solely with natural phages can be a time-, labor- and cost-intensive process. Here, we present a synthetic-biology strategy to modulate phage host ranges by engineering phage genomes in . We used this technology to redirect phage scaffolds to target pathogenic and bacteria, and conversely, phage scaffolds to target by modular swapping of phage tail components. The synthetic phages achieved efficient killing of their new target bacteria and were used to selectively remove bacteria from multi-species bacterial communities with cocktails based on common viral scaffolds. We envision that this approach will accelerate phage-biology studies and enable new technologies for bacterial population editing.

Citing Articles

Oral bacteriophages and their potential as adjunctive treatments for periodontitis: a narrative review.

Kabwe M, Tucci J, Darby I, Dashper S J Oral Microbiol. 2025; 17(1):2469890.

PMID: 40013014 PMC: 11864011. DOI: 10.1080/20002297.2025.2469890.


Exploring the principles behind antibiotics with limited resistance.

Maharramov E, Czikkely M, Szili P, Farkas Z, Grezal G, Daruka L Nat Commun. 2025; 16(1):1842.

PMID: 39984459 PMC: 11845477. DOI: 10.1038/s41467-025-56934-3.


Engineering bacteriophages for targeted superbug eradication.

Ghaznavi G, Vosough P, Ghasemian A, Tabar M, Tayebi L, Taghizadeh S Mol Biol Rep. 2025; 52(1):221.

PMID: 39934535 DOI: 10.1007/s11033-025-10332-6.


Synthesis of Headful Packaging Phages Through Yeast Transformation-Associated Recombination.

Lu C, He L, Guo Y, Wang T, Ye Y, Lin Z Viruses. 2025; 17(1).

PMID: 39861840 PMC: 11769102. DOI: 10.3390/v17010045.


Antibiotic Resistance of Strains-Searching for New Antimicrobial Agents-Review.

Michalik M, Podbielska-Kubera A, Dmowska-Koroblewska A Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861144 PMC: 11768290. DOI: 10.3390/ph18010081.


References
1.
Bikard D, Euler C, Jiang W, Nussenzweig P, Goldberg G, Duportet X . Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat Biotechnol. 2014; 32(11):1146-50. PMC: 4317352. DOI: 10.1038/nbt.3043. View

2.
Jaschke P, Lieberman E, Rodriguez J, Sierra A, Endy D . A fully decompressed synthetic bacteriophage øX174 genome assembled and archived in yeast. Virology. 2012; 434(2):278-84. DOI: 10.1016/j.virol.2012.09.020. View

3.
Trojet S, Caumont-Sarcos A, Perrody E, Comeau A, Krisch H . The gp38 adhesins of the T4 superfamily: a complex modular determinant of the phage's host specificity. Genome Biol Evol. 2011; 3:674-86. PMC: 3157838. DOI: 10.1093/gbe/evr059. View

4.
Shin J, Jardine P, Noireaux V . Genome replication, synthesis, and assembly of the bacteriophage T7 in a single cell-free reaction. ACS Synth Biol. 2013; 1(9):408-13. DOI: 10.1021/sb300049p. View

5.
Kiro R, Shitrit D, Qimron U . Efficient engineering of a bacteriophage genome using the type I-E CRISPR-Cas system. RNA Biol. 2014; 11(1):42-4. PMC: 3929423. DOI: 10.4161/rna.27766. View